MA31236B1 - Utilisation de chitosane pour augmenter le taux de croissance des ongles - Google Patents
Utilisation de chitosane pour augmenter le taux de croissance des onglesInfo
- Publication number
- MA31236B1 MA31236B1 MA32200A MA32200A MA31236B1 MA 31236 B1 MA31236 B1 MA 31236B1 MA 32200 A MA32200 A MA 32200A MA 32200 A MA32200 A MA 32200A MA 31236 B1 MA31236 B1 MA 31236B1
- Authority
- MA
- Morocco
- Prior art keywords
- chitosan
- growth rate
- nails
- nail
- nail growth
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
- A61Q3/02—Nail coatings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
La présente invention concerne l'utilisation de chitosane, d'un dérivé de chitosane ou d'un sel physiologiquement acceptable de celui-ci, pour augmenter le taux de croissance des ongles. La présente invention concerne en outre l'utilisation de chitosane pour accélérer le taux de croissance des ongles lors d'un traitement contre une maladie des ongles, une dystrophie des ongles ou d'autres conditions des ongles, afin de raccourcir considérablement les traitements spécifiques desdites maladies des ongles, de ladite dystrophie ou desdites autres conditions des ongles.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07102335A EP1958638A1 (fr) | 2007-02-14 | 2007-02-14 | Utilisation de chitosanes pour augmenter la vitesse de pousse des ongles |
PCT/EP2008/051477 WO2008098869A2 (fr) | 2007-02-14 | 2008-02-07 | Utilisation de chitosane pour augmenter le taux de croissance des ongles |
Publications (1)
Publication Number | Publication Date |
---|---|
MA31236B1 true MA31236B1 (fr) | 2010-03-01 |
Family
ID=38345983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA32200A MA31236B1 (fr) | 2007-02-14 | 2009-09-04 | Utilisation de chitosane pour augmenter le taux de croissance des ongles |
Country Status (32)
Country | Link |
---|---|
US (3) | US8680074B2 (fr) |
EP (3) | EP1958638A1 (fr) |
JP (3) | JP5426401B2 (fr) |
KR (2) | KR101323762B1 (fr) |
CN (2) | CN101663039B (fr) |
AR (1) | AR065316A1 (fr) |
AT (1) | ATE522221T1 (fr) |
AU (1) | AU2008214693B2 (fr) |
BR (1) | BRPI0807595A2 (fr) |
CA (1) | CA2677715C (fr) |
CL (2) | CL2008000444A1 (fr) |
CO (1) | CO6230979A2 (fr) |
CY (2) | CY1112058T1 (fr) |
DK (2) | DK2117564T3 (fr) |
EA (2) | EA201270116A1 (fr) |
ES (2) | ES2369116T3 (fr) |
HK (1) | HK1133189A1 (fr) |
HR (2) | HRP20110667T1 (fr) |
IL (1) | IL200269A (fr) |
MA (1) | MA31236B1 (fr) |
ME (1) | ME00830B (fr) |
MX (1) | MX2009008686A (fr) |
MY (2) | MY163297A (fr) |
NZ (1) | NZ578896A (fr) |
PH (1) | PH12014500274A1 (fr) |
PL (2) | PL2117564T3 (fr) |
PT (2) | PT2117564E (fr) |
RS (2) | RS52031B (fr) |
SI (2) | SI2377541T1 (fr) |
UA (1) | UA100011C2 (fr) |
WO (1) | WO2008098869A2 (fr) |
ZA (1) | ZA200905443B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10201490B2 (en) * | 2007-02-14 | 2019-02-12 | Polichem Sa | Use of chitosans for the treatment of nail inflammatory diseases |
WO2010109423A1 (fr) * | 2009-03-25 | 2010-09-30 | Sulur Subramaniam Vanangamudi | Crème médicinale antifongique à base de stéroïdes et comprenant du chitosane, et son procédé de fabrication |
CN103987370A (zh) * | 2011-10-05 | 2014-08-13 | 阿勒根公司 | 用于增进指甲健康的组合物 |
EP2793946B1 (fr) * | 2011-12-20 | 2019-03-06 | Urgo Recherche Innovation et Développement | Composition topique filmogène et son utilisation pour traiter ou prévenir l'onychophagie |
US8697753B1 (en) | 2013-02-07 | 2014-04-15 | Polichem Sa | Method of treating onychomycosis |
EP2845597A1 (fr) * | 2013-09-10 | 2015-03-11 | Polichem S.A. | Hydroxypropylchitosan pour le traitement de l'onychomycose |
EP2910245A1 (fr) * | 2014-02-21 | 2015-08-26 | Polichem SA | Composition antifongique topique pour le traitement de l'onychomycose |
CN109893472A (zh) * | 2019-04-09 | 2019-06-18 | 涿州皓原箔业有限公司 | 一种环保无毒水性卸甲液及其制备方法 |
ES2834732B2 (es) * | 2019-12-17 | 2022-03-24 | Univ Valladolid | Solucion acuosa que comprende un complejo de inclusion, metodo de obtencion y su uso para aplicacion en cultivos y la mejora de su rendimiento |
CN111388416B (zh) * | 2020-02-26 | 2022-03-08 | 浙江康德药业集团股份有限公司 | 一种盐酸利多卡因胶浆剂 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3541305A1 (de) | 1985-11-22 | 1987-05-27 | Wella Ag | Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung |
DE3723811A1 (de) * | 1987-07-18 | 1989-01-26 | Wella Ag | Nagellack auf der basis von o-benzyl-n-hydroxyalkylchitosanen sowie neue o-benzyl-n-hydroxyalkylderivate des chitosans |
CA2008775C (fr) | 1989-02-24 | 1998-12-22 | Alberto Ferro | Vernis a ongles |
ES2101263T3 (es) | 1993-02-19 | 1997-07-01 | Howard Green | Composiciones que contienen proteinas de corneocitos. |
FR2718637A1 (fr) * | 1994-04-15 | 1995-10-20 | Oreal | Composition cosmétique à appliquer sur l'ongle. |
RU2108114C1 (ru) * | 1996-12-27 | 1998-04-10 | Товарищество с ограниченной ответственностью Научно-производственное предприятие "Эрлон", Лтд. | Биологическая композиция для лечения ран "коллахит" |
ITTO980264A1 (it) | 1998-03-26 | 1999-09-26 | Silvio Rossi | Applicazione di un estratto basico non quaternario della peschiera fuchsiaefolia ad attivita' antimalarica |
US6391334B1 (en) * | 1999-10-25 | 2002-05-21 | Amway Corporation | Barrier-forming composition |
DE10035991A1 (de) * | 2000-07-24 | 2002-02-14 | Polichem Sa | Nagellackzusammensetzung |
PT1455802E (pt) * | 2001-12-14 | 2008-11-03 | Dnp Canada Inc | Oligossacáridos de quitosano e suas utilizações |
EP1440683A1 (fr) * | 2003-01-23 | 2004-07-28 | Cognis France S.A. | Utilisation des oligoglucosamines dans des compositions cosmétiques ou dermatologiques |
EP1491202A1 (fr) * | 2003-06-23 | 2004-12-29 | Polichem S.A. | Compositions pour l'application à la surface d'ongles pour les réstructurer |
JP3881992B2 (ja) | 2004-07-30 | 2007-02-14 | シャープ株式会社 | 受信装置、受信プログラム、および受信プログラムを記録した記録媒体 |
WO2006111426A1 (fr) * | 2005-04-19 | 2006-10-26 | Galderma S.A. | Composition d'une solution de type filmogene, comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie |
FR2892023B1 (fr) * | 2005-10-14 | 2009-09-25 | Galderma Sa | Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale |
DE102006049585A1 (de) | 2006-10-22 | 2008-04-24 | Susilo, Rudy, Dr. | Nagellack für kosmetische und medizinische Anwendungen |
-
2007
- 2007-02-14 EP EP07102335A patent/EP1958638A1/fr not_active Withdrawn
-
2008
- 2008-02-07 UA UAA200908419A patent/UA100011C2/ru unknown
- 2008-02-07 EP EP08716765A patent/EP2117564B1/fr active Active
- 2008-02-07 EA EA201270116A patent/EA201270116A1/ru unknown
- 2008-02-07 ZA ZA200905443A patent/ZA200905443B/xx unknown
- 2008-02-07 MY MYPI2014000324A patent/MY163297A/en unknown
- 2008-02-07 US US12/449,573 patent/US8680074B2/en not_active Expired - Fee Related
- 2008-02-07 BR BRPI0807595-6A2A patent/BRPI0807595A2/pt not_active IP Right Cessation
- 2008-02-07 NZ NZ578896A patent/NZ578896A/en not_active IP Right Cessation
- 2008-02-07 PT PT08716765T patent/PT2117564E/pt unknown
- 2008-02-07 KR KR1020117012108A patent/KR101323762B1/ko not_active IP Right Cessation
- 2008-02-07 PL PL08716765T patent/PL2117564T3/pl unknown
- 2008-02-07 CA CA2677715A patent/CA2677715C/fr not_active Expired - Fee Related
- 2008-02-07 CN CN2008800049909A patent/CN101663039B/zh not_active Expired - Fee Related
- 2008-02-07 AT AT08716765T patent/ATE522221T1/de active
- 2008-02-07 ES ES08716765T patent/ES2369116T3/es active Active
- 2008-02-07 EP EP11172347.4A patent/EP2377541B1/fr active Active
- 2008-02-07 SI SI200831116T patent/SI2377541T1/sl unknown
- 2008-02-07 RS RS20110443A patent/RS52031B/en unknown
- 2008-02-07 RS RS20130569A patent/RS53143B/en unknown
- 2008-02-07 DK DK08716765.6T patent/DK2117564T3/da active
- 2008-02-07 PT PT111723474T patent/PT2377541E/pt unknown
- 2008-02-07 ES ES11172347.4T patent/ES2436647T3/es active Active
- 2008-02-07 DK DK11172347.4T patent/DK2377541T3/da active
- 2008-02-07 CN CN2012102916935A patent/CN102988405A/zh active Pending
- 2008-02-07 SI SI200830430T patent/SI2117564T1/sl unknown
- 2008-02-07 MX MX2009008686A patent/MX2009008686A/es active IP Right Grant
- 2008-02-07 MY MYPI20093349A patent/MY154499A/en unknown
- 2008-02-07 PL PL11172347T patent/PL2377541T3/pl unknown
- 2008-02-07 JP JP2009549395A patent/JP5426401B2/ja not_active Expired - Fee Related
- 2008-02-07 WO PCT/EP2008/051477 patent/WO2008098869A2/fr active Application Filing
- 2008-02-07 EA EA200901093A patent/EA018390B1/ru not_active IP Right Cessation
- 2008-02-07 AU AU2008214693A patent/AU2008214693B2/en not_active Ceased
- 2008-02-07 KR KR1020097018790A patent/KR101131015B1/ko not_active IP Right Cessation
- 2008-02-07 ME MEP-2009-271A patent/ME00830B/fr unknown
- 2008-02-12 AR ARP080100602A patent/AR065316A1/es unknown
- 2008-02-12 CL CL200800444A patent/CL2008000444A1/es unknown
-
2009
- 2009-08-06 IL IL200269A patent/IL200269A/en not_active IP Right Cessation
- 2009-09-04 MA MA32200A patent/MA31236B1/fr unknown
- 2009-09-14 CO CO09098720A patent/CO6230979A2/es active IP Right Grant
- 2009-12-03 HK HK09111316.5A patent/HK1133189A1/xx not_active IP Right Cessation
-
2011
- 2011-09-15 HR HR20110667T patent/HRP20110667T1/hr unknown
- 2011-11-22 CY CY20111101125T patent/CY1112058T1/el unknown
-
2013
- 2013-07-12 JP JP2013146717A patent/JP2013213048A/ja active Pending
- 2013-07-15 CL CL2013002052A patent/CL2013002052A1/es unknown
- 2013-12-04 CY CY20131101097T patent/CY1115136T1/el unknown
- 2013-12-10 HR HRP20131175AT patent/HRP20131175T1/hr unknown
-
2014
- 2014-01-29 US US14/167,273 patent/US9173827B2/en not_active Expired - Fee Related
- 2014-01-30 PH PH12014500274A patent/PH12014500274A1/en unknown
-
2015
- 2015-08-14 JP JP2015160157A patent/JP6045663B2/ja not_active Expired - Fee Related
- 2015-09-30 US US14/870,684 patent/US20160015620A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA31236B1 (fr) | Utilisation de chitosane pour augmenter le taux de croissance des ongles | |
MY171300A (en) | Pharmaceutical composition | |
MX338421B (es) | Anticuerpos fosfoespecificos que reconocen la proteina tau. | |
MX354662B (es) | Anticuerpos fosfoespecificos que reconocen la tau. | |
WO2010065824A3 (fr) | Agents induisant l'apoptose pour le traitement du cancer et de maladies immunes et auto-immunes | |
MX2009008253A (es) | Derivados de 2-aminopiridina utiles como inhibidores de cinasa. | |
NO20092651L (no) | Dihydropyridinderivater som er anvendelige som proteinkinaseinhibitorer | |
MX2009006345A (es) | Compuestos utiles como inhibidores de proteina cinasa. | |
WO2009149486A3 (fr) | Composés destinés au traitement de maladies | |
EA200901211A1 (ru) | Антигены белка с5 и их применение | |
WO2008079372A3 (fr) | Nouvelles compositions immunogènes pour la prévention et le traitement d'une maladie méningococcique | |
TNSN07401A1 (fr) | Anticorps diriges contre le peptide amyloide-beta, et methodes pour leurs utilisations | |
NO20084396L (no) | Kombinasjonsterapi | |
WO2009149485A3 (fr) | Composés destinés au traitement des amyloïdoses | |
EP2438962A3 (fr) | Polynucléotides et séquences de polypeptides impliqués dans le procédé de remodelage des os | |
WO2010007031A3 (fr) | Procédés pour améliorer la différenciation cardiaque des cellules souches embryonnaires humaines | |
WO2006113790A3 (fr) | Compositions et procedes pour le traitement du cancer | |
EA201390310A1 (ru) | Фармацевтические композиции, содержащие рифаксимин, способы их получения и способ лечения кишечного заболевания | |
WO2011035205A3 (fr) | Anticorps dirigés contre candida, leurs collectes et procédés d'utilisation | |
WO2010042489A3 (fr) | Inhibiteurs de la protéine de choc thermique 90 dérivés d'aminoquinoline, leurs procédés de préparation et leurs procédés d'utilisation | |
WO2008127680A3 (fr) | Diagnostic et traitement de maladies causées par des protéines mal pliées | |
FR2933609B1 (fr) | Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson. | |
WO2010069335A3 (fr) | Diagnostic de l'endométrite | |
FR2942720B1 (fr) | Utilisation cosmetique d'hesperidine. | |
EP2275547A3 (fr) | Polynucléotides et séquences de polypeptide impliquées dans le procédé de remodelage des os |